Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Non-cash Items: 2017-2022

Historic Non-cash Items for Arcus Biosciences (RCUS) over the last 6 years, with Dec 2022 value amounting to $50.0 million.

  • Arcus Biosciences' Non-cash Items fell 80.29% to $50.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $50.0 million, marking a year-over-year decrease of 80.29%. This contributed to the annual value of $50.0 million for FY2022, which is 869.32% up from last year.
  • Arcus Biosciences' Non-cash Items amounted to $50.0 million in FY2022, which was up 869.32% from $5.2 million recorded in FY2021.
  • Arcus Biosciences' 5-year Non-cash Items high stood at $50.0 million for FY2022, and its period low was $238,721 during FY2018.
  • Its 3-year average for Non-cash Items is $19.3 million, with a median of $5.2 million in 2021.
  • In the last 5 years, Arcus Biosciences' Non-cash Items tumbled by 87.44% in 2018 and then skyrocketed by 869.32% in 2022.
  • Over the past 5 years, Arcus Biosciences' Non-cash Items (Yearly) stood at $238,721 in 2018, then spiked by 379.77% to $1.1 million in 2019, then spiked by 143.87% to $2.8 million in 2020, then spiked by 84.68% to $5.2 million in 2021, then skyrocketed by 869.32% to $50.0 million in 2022.